Barclays »

Gyre Therapeutics Incorporated shares owned by Barclays

Quarter-by-quarter ownership of Gyre Therapeutics Incorporated (GYRE) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Gyre Therapeutics Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Gyre Therapeutics Incorporated held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gyre Therapeutics Incorporated by Barclays

Quarter filed Position value Share count Share price at filing
2025-09-30 $100k 13k 7.46
2025-06-30 $176k 24k 7.33
2025-03-31 $65k 8.5k 7.68
2024-12-31 $128k 11k 12.14
2024-09-30 $116k 9.3k 12.49
2024-06-30 $29k 2.4k 11.92

More positions owned by Barclays

Microsoft Corporation (MSFT)
SPDR S&ampP 500 ETF TR Fund (SPY)
Invesco Qqq Tr Fund (QQQ)
NVIDIA Corporation (NVDA)
Ishares Tr Fund (IWM)
Apple (AAPL)
Tesla Opt Put Option (TSLA)
Amazon Opt Call Option (AMZN)
Alphabet Opt Call Option (GOOGL)
Broadcom Opt Call Option (AVGO)
Facebook Inc cl a (META)
Ishares Tr Opt Call Option (HYG)
JPMorgan Chase & Co. (JPM)
Alphabet Opt Put Option (GOOG)
Berkshire Hathaway Inc Del Opt Put Option (BRK.B)

View all positions for Barclays

Top funds holding Gyre Therapeutics Incorporated

Vanguard Group
BlackRock
Geode Capital Management
State Street Corporation
SBI Securities
Charles Schwab Investment Management
Northern Trust
State of Wisconsin Investment Board
Millennium Management
Morgan Stanley
Bank of New York Mellon
UBS Group
Alliancebernstein
OTR - Nominee Name for The State Teachers Retirement Board of Ohio
Goldman Sachs Group

View all funds holding Gyre Therapeutics Incorporated